Kiora Pharmaceuticals Balance Sheet (2014-2026)

Reported Financials

Kiora Pharmaceuticals Quarterly Balance Sheet

Periods 50 quarters

Latest Jun 2026

Kiora Pharmaceuticals reported total assets of $23.78M and total liabilities of $6.92M for the quarter ended Jun 2026, down 25.6% year over year. This balance sheet covers 50 quarters of results from Mar 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Accumulated Depreciation	0.11M	0.11M
Receivables - AccuredAcc. Int. Receivables
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	11.15M	7.90M	5.11M	2.48M	4.85M	6.01M	3.43M	7.96M	5.40M	2.46M	31.28M	6.58M	5.64M	3.80M	3.78M	1.03M	5.51M	8.70M	11.00M	7.10M
Receivables - NetNet Receivables											0.19M	1.34M	1.78M	0.60M	1.34M	2.42M	1.21M	1.52M	1.54M	1.09M
Receivables - OtherOther Receivables
Receivables											0.19M	1.34M	1.78M	0.60M	1.34M	2.42M	1.21M	1.52M	1.54M	1.09M
Prepaid Assets	0.34M	0.61M	0.93M	1.40M	0.26M	0.34M	0.49M	0.27M	0.24M	0.23M	0.21M	0.34M	0.47M	2.04M	0.94M	0.96M	0.65M	1.14M	1.21M	1.13M
Current Assets	11.87M	8.99M	6.55M	4.38M	6.62M	7.68M	5.62M	9.02M	6.98M	4.74M	33.48M	31.83M	31.65M	29.71M	27.11M	24.74M	22.69M	21.75M	18.68M	21.26M
Non-Current Assets
Property, Plant & Equipment (Net)	0.08M	0.07M	0.07M	0.06M	0.06M	0.06M	0.05M	0.04M	0.04M	0.01M	0.01M	0.06M	0.06M	0.01M	0.00M	0.11M	0.10M	0.09M	0.09M	0.10M
Goodwill	3.48M
Intangibles	9.71M	10.77M	10.76M	10.76M	10.75M	10.74M	10.74M	10.73M	8.82M	8.81M	8.81M	8.80M	6.69M	6.69M	6.69M	6.69M	6.69M	2.06M	2.06M	2.06M
Goodwill & Intangibles	13.20M	10.77M	10.76M	10.76M	10.75M	10.74M	10.74M	10.73M	8.82M	8.81M	8.81M	8.80M	6.69M	6.69M	6.69M	6.69M	6.69M	2.06M	2.06M	2.06M
Other Non-Current Assets	0.04M	0.04M	0.05M	0.05M	0.05M	0.05M	0.03M	0.03M	0.03M	0.04M	0.04M	0.03M	0.03M	0.02M	0.06M	0.06M	0.06M	0.06M	0.09M	0.09M
Non-Current Assets	13.62M	11.14M	11.09M	11.08M	11.04M	11.00M	10.91M	10.86M	8.91M	8.97M	8.96M	8.98M	6.86M	6.78M	6.91M	7.21M	7.17M	2.50M	2.54M	2.51M
Assets	25.49M	20.13M	17.64M	15.46M	17.66M	18.68M	16.53M	19.88M	15.90M	13.71M	42.44M	40.81M	38.51M	36.48M	34.02M	31.95M	29.86M	24.25M	21.23M	23.78M
Liabilities
Current Liabilities
Accounts Payables	0.42M	0.16M	0.30M	0.79M	0.75M	1.01M	0.59M	0.13M	0.13M	0.21M	0.32M	0.27M	0.66M	0.42M	0.94M	0.28M	0.24M	1.06M	0.59M	0.22M
Notes Payables
Payables	0.42M	0.16M	0.30M	0.79M	0.75M	1.01M	0.59M	0.13M	0.13M	0.21M	0.32M	0.27M	0.66M	0.42M	0.94M	0.28M	0.24M	1.06M	0.59M	0.22M
Accumulated Expenses	1.39M	1.33M	1.83M	1.63M	1.80M	1.84M	1.18M	1.40M	1.46M	1.38M	1.22M	1.35M	1.71M	4.59M	3.52M	2.54M	2.15M	2.41M	2.03M	1.98M
Other Accumulated Expenses		0.03M			0.02M
Current Leases
Current Deferred Revenue
Total Current Liabilities	1.96M	1.61M	2.52M	2.86M	2.99M	3.27M	2.16M	1.88M	2.10M	1.63M	1.59M	1.66M	3.53M	6.01M	5.27M	3.19M	2.58M	3.63M	2.80M	2.37M
Non-Current Liabilities
Capital Leases
Non-Current Debt
Non-Current Deffered Revenue																1.25M	1.25M	1.25M	1.25M	1.25M
Preferred Stock Liabilities
Minority Interest
Operating Leases	0.11M	0.09M	0.07M	0.03M	0.00M					0.06M	0.05M	0.04M	0.04M	0.03M	0.09M	0.29M	0.25M	0.20M	0.20M	0.16M
Non-Current Deferred Tax Liability	0.73M	0.80M	0.80M	0.80M	0.80M	0.69M	0.69M	0.69M	0.69M	0.78M	0.78M	0.78M	0.78M	0.49M	0.49M	0.49M	0.49M	0.10M	0.10M	0.10M
Other Non-Current Liabilities	5.34M	3.05M	18.80M	18.80M	18.80M	3.31M	18.80M	18.80M	18.80M	5.13M	18.80M	18.80M	16.64M	4.19M	16.64M	16.64M	16.64M	2.94M	16.64M	16.64M
Total Non-Current Liabilities	6.19M	3.94M	3.86M	3.84M	4.15M	4.00M	4.22M	4.36M	5.69M	5.97M	5.94M	6.06M	4.95M	4.72M	5.04M	6.63M	4.87M	4.50M	4.49M	4.55M
Total Liabilities	8.15M	5.55M	6.38M	6.70M	7.14M	7.27M	6.37M	6.24M	7.79M	7.60M	7.54M	7.71M	8.48M	10.72M	10.32M	9.82M	7.45M	8.13M	7.29M	6.92M
Shareholder's Equity
Total Debt
Common Equity	17.35M	14.58M	11.26M	8.76M	10.52M	11.41M	10.16M	13.64M	8.10M	6.11M	34.90M	33.10M	30.03M	25.76M	23.70M	22.13M	22.41M	16.13M	13.93M	16.86M
Liabilities and Shareholders Equity	25.49M	20.13M	17.64M	15.46M	17.66M	18.68M	16.53M	19.88M	15.90M	13.71M	42.44M	40.81M	38.51M	36.48M	34.02M	31.95M	29.86M	24.25M	21.23M	23.78M
Retained Earnings	-116.36M	-120.88M	-124.44M	-126.85M	-131.97M	-134.46M	-136.33M	-138.95M	-144.71M	-146.98M	-133.52M	-135.75M	-139.20M	-143.38M	-145.60M	-147.73M	-147.70M	-154.22M	-156.64M	-158.71M
Preferred Shares								10.00	5.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00

Kiora Pharmaceuticals Balance Sheet API

Pull Kiora Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=KPRX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "KPRX", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=KPRX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Kiora Pharmaceuticals KPRX Balance Sheet (2014-2026)

Kiora Pharmaceuticals Quarterly Balance Sheet

Kiora Pharmaceuticals Balance Sheet API

Create an account

Sign In

Reset Password